Abstract
Purpose
Limited numbers of literatures have focused on the association between γ-glutamyltransferase (GGT) and chronic kidney disease (CKD), and their results were controversial. Therefore, in this study, we set up a large-scale cohort of Chinese population to discover and verify the association between serum GGT and CKD.
Methods
Our cohort study was based on 21,818 patients who visited Health Management Center of Shandong Provincial Hospital, China, to receive routine health check-up during the period of 2005–2010, and we used multivariate Cox regression model to clarify whether elevated serum GGT increased the risk of CKD or not.
Results
During the follow-up of 57,891 person-years, 1456 patients developed CKD, giving rise to an incidence density of 25.15 per 1000 person-years (1456/57,891 person-years). After adjusting gender, age, baseline serum creatinine (SCr), body mass index (BMI), serum albumin (ALB), alanine aminotransferase (ALT), hemoglobin, white blood cell count (WBC), triglyceride (TG), total cholesterol (TC), hypertension, cardiovascular disease (CVD), diabetes, smoking and drinking status, the risk for CKD increased with the elevated serum GGT quartiles. The hazard ratio (HR) for CKD was 1.326 (95 % confidence interval (CI), 1.073–1.639) when the top quartile of serum GGT was compared with the bottom one, and the HR of log-transformed serum GGT for CKD was 1.658 (95 % CI, 1.294–2.125). The results were consistent in males but different in females when gender was stratified.
Conclusion
The result reveals that there is a positive relationship between increasing serum GGT levels and the incidence of CKD which suggests that elevated GGT level could be a potential indicator for risk of CKD.
Similar content being viewed by others
References
Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ et al (2007) Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from kidney disease improving global outcomes. Kidney Int 72:247–259. doi:10.1038/sj.ki.5002343
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S et al (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382:260–272. doi:10.1016/S0140-6736(13)60687-X
Minutolo R, De Nicola L, Mazzaglia G, Postorino M, Cricelli C et al (2008) Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy. Am J Kidney Dis 52:444–453. doi:10.1053/j.ajkd.2008.03.002
Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW et al (2005) Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16:180–188. doi:10.1681/ASN.2004070539
Liu Q, Li Z, Wang H, Chen X, Dong X et al (2012) High prevalence and associated risk factors for impaired renal function and urinary abnormalities in a rural adult population from southern China. PLoS ONE 7:e47100. doi:10.1371/journal.pone.0047100
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128. doi:10.1016/S0140-6736(12)61728-0
Nugent RA, Fathima SF, Feigl AB, Chyung D (2011) The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract 118:c269–c277. doi:10.1159/000321382
Zhang L, Wang F, Wang L, Wang W, Liu B et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379:815–822. doi:10.1016/S0140-6736(12)60033-6
Conigrave KM, Davies P, Haber P, Whitfield JB (2003) Traditional markers of excessive alcohol use. Addiction 98(Suppl 2):31–43
Niemela O, Alatalo P (2010) Biomarkers of alcohol consumption and related liver disease. Scand J Clin Lab Invest 70:305–312. doi:10.3109/00365513.2010.486442
Heisterkamp N, Groffen J, Warburton D, Sneddon TP (2008) The human gamma-glutamyltransferase gene family. Hum Genet 123:321–332. doi:10.1007/s00439-008-0487-7
Whitfield JB (2001) Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38:263–355. doi:10.1080/20014091084227
Lee DH, Blomhoff R, Jacobs DJ (2004) Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 38:535–539
Lim JS, Yang JH, Chun BY, Kam S, Jacobs DJ et al (2004) Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? Free Radic Biol Med 37:1018–1023. doi:10.1016/j.freeradbiomed.2004.06.032
Liu CF, Gu YT, Wang HY, Fang NY (2012) Gamma-glutamyltransferase level and risk of hypertension: a systematic review and meta-analysis. PLoS ONE 7:e48878. doi:10.1371/journal.pone.0048878
Kunutsor SK, Apekey TA, Cheung BM (2015) Gamma-glutamyltransferase and risk of hypertension: a systematic review and dose-response meta-analysis of prospective evidence. J Hypertens 33:2373–2381. doi:10.1097/HJH.0000000000000763
Nakanishi N, Nishina K, Li W, Sato M, Suzuki K et al (2003) Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med 254:287–295
Jimba S, Nakagami T, Oya J, Wasada T, Endo Y et al (2009) Increase in gamma-glutamyltransferase level and development of established cardiovascular risk factors and diabetes in Japanese adults. Metab Syndr Relat Disord 7:411–418. doi:10.1089/met.2008.0082
Akgul O, Uyarel H (2014) G-glutamyl transferase: a novel prognostic marker for cardiovascular disease. J Crit Care 29:167–168. doi:10.1016/j.jcrc.2013.10.024
Kim KM, Kim BT, Lee DJ, Park SB, Joo NS et al (2012) Serum gamma-glutamyltransferase as a risk factor for general cardiovascular disease prediction in Koreans. J Investig Med 60:1199–1203. doi:10.231/JIM.0b013e3182746752
Han KS, Cho DY, Kim YS, Kim KN (2015) Serum gamma-glutamyl transferase concentration within the reference range is related to the coronary heart disease risk prediction in Korean men: analysis of the Korea national health and nutrition examination survey (V-1, 2010 and V-2, 2011). Chin Med J (Engl) 128:2006–2011. doi:10.4103/0366-6999.161343
Ess M, Mussner-Seeber C, Mariacher S, Lorsbach-Koehler A, Pachinger O et al (2011) gamma-Glutamyltransferase rather than total bilirubin predicts outcome in chronic heart failure. J Card Fail 17:577–584. doi:10.1016/j.cardfail.2011.02.012
Liu CF, Zhou WN, Fang NY (2012) Gamma-glutamyltransferase levels and risk of metabolic syndrome: a meta-analysis of prospective cohort studies. Int J Clin Pract 66:692–698. doi:10.1111/j.1742-1241.2012.02959.x
Kunutsor SK, Apekey TA, Seddoh D (2015) Gamma glutamyltransferase and metabolic syndrome risk: a systematic review and dose-response meta-analysis. Int J Clin Pract 69:136–144. doi:10.1111/ijcp.12507
Ryu S, Chang Y, Kim DI, Kim WS, Suh BS (2007) Gamma-glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem 53:71–77. doi:10.1373/clinchem.2006.078980
Teppala S, Shankar A, Li J, Wong TY, Ducatman A (2010) Association between serum gamma-glutamyltransferase and chronic kidney disease among US adults. Kidney Blood Press Res 33:1–6. doi:10.1159/000274463
Cain LR, Ducatman AM, Shankar A (2012) The relationship between gamma-glutamyl transferase levels and chronic kidney disease among Appalachian adults. W Va Med J 108:8–13
Noborisaka Y, Ishizaki M, Yamazaki M, Honda R, Yamada Y (2013) Elevated serum gamma-glutamyltransferase (GGT) activity and the development of chronic kidney disease (CKD) in cigarette smokers. Nephrourol Mon 5:967–973. doi:10.5812/numonthly.13652
Ishigami T, Yamamoto R, Nagasawa Y, Isaka Y, Rakugi H et al (2014) An association between serum gamma-glutamyltransferase and proteinuria in drinkers and non-drinkers: a Japanese nationwide cross-sectional survey. Clin Exp Nephrol 18:899–910. doi:10.1007/s10157-014-0938-5
Stevens PE, Levin A (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158:825–830. doi:10.7326/0003-4819-158-11-201306040-00007
Thamer C, Tschritter O, Haap M, Shirkavand F, Machann J et al (2005) Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res 37:246–251. doi:10.1055/s-2005-861411
Lee DH, Jacobs DJ, Gross M, Kiefe CI, Roseman J et al (2003) Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the coronary artery risk development in young adults (CARDIA) study. Clin Chem 49:1358–1366
Modaresi A, Nafar M, Sahraei Z (2015) Oxidative stress in chronic kidney disease. Iran J Kidney Dis 9:165–179
Cochrane AL, Ricardo SD (2003) Oxidant stress and regulation of chemokines in the development of renal interstitial fibrosis. Contrib Nephrol 139:102–119
Ricardo SD, Diamond JR (1998) The role of macrophages and reactive oxygen species in experimental hydronephrosis. Semin Nephrol 18:612–621
Kim JI, Noh MR, Kim KY, Jang HS, Kim HY et al (2015) Methionine sulfoxide reductase A deficiency exacerbates progression of kidney fibrosis induced by unilateral ureteral obstruction. Free Radic Biol Med 89:201–208. doi:10.1016/j.freeradbiomed.2015.07.018
Boor P, Ostendorf T, Floege J (2010) Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 6:643–656. doi:10.1038/nrneph.2010.120
Jung KJ, Min KJ, Park JW, Park KM, Kwon TK (2016) Carnosic acid attenuates unilateral ureteral obstruction-induced kidney fibrosis via inhibition of Akt-mediated Nox4 expression. Free Radic Biol Med 97:50–57. doi:10.1016/j.freeradbiomed.2016.05.020
Koenig G, Seneff S (2015) Gamma-Glutamyltransferase: a Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk. Dis Markers 2015:818570. doi:10.1155/2015/818570
Evans RG, Fitzgerald SM (2005) Nitric oxide and superoxide in the renal medulla: a delicate balancing act. Curr Opin Nephrol Hypertens 14:9–15
Yilmaz MI, Turgut F, Kanbay M, Saglam M, Sonmez A et al (2013) Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease. Int Urol Nephrol 45:1071–1078. doi:10.1007/s11255-012-0354-2
Khaira A, Mahajan S, Kumar A, Saraya A, Tiwari SC et al (2011) Endothelial function and oxidative stress in chronic kidney disease of varying severity and the effect of acute hemodialysis. Ren Fail 33:411–417. doi:10.3109/0886022X.2011.568138
Sakemi T, Toyoshima H, Morito F (1994) Testosterone eliminates the attenuating effect of castration on the progressive glomerular injury in hypercholesterolemic male Imai rats. Nephron 67:469–476
Kummer S, von Gersdorff G, Kemper MJ, Oh J (2012) The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease. Pediatr Nephrol 27:1213–1219. doi:10.1007/s00467-011-1963-1
Acknowledgments
This work was funded by Shandong Province outstanding young scientist research award fund (BS2014YY021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflict of interest.
Additional information
Zhen-Wei Shen and Jie Xing have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Shen, ZW., Xing, J., Wang, QL. et al. Association between serum γ-glutamyltransferase and chronic kidney disease in urban Han Chinese: a prospective cohort study. Int Urol Nephrol 49, 303–312 (2017). https://doi.org/10.1007/s11255-016-1429-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-016-1429-2